GB2052487B - Pyrimidine compounds and pharmaceutical preprations containing them - Google Patents
Pyrimidine compounds and pharmaceutical preprations containing themInfo
- Publication number
- GB2052487B GB2052487B GB8016309A GB8016309A GB2052487B GB 2052487 B GB2052487 B GB 2052487B GB 8016309 A GB8016309 A GB 8016309A GB 8016309 A GB8016309 A GB 8016309A GB 2052487 B GB2052487 B GB 2052487B
- Authority
- GB
- United Kingdom
- Prior art keywords
- preprations
- pharmaceutical
- pyrimidine compounds
- pyrimidine
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH466979 | 1979-05-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2052487A GB2052487A (en) | 1981-01-28 |
GB2052487B true GB2052487B (en) | 1983-05-11 |
Family
ID=4280399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8016309A Expired GB2052487B (en) | 1979-05-18 | 1980-05-16 | Pyrimidine compounds and pharmaceutical preprations containing them |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0019811A1 (en) |
JP (1) | JPS55154971A (en) |
KR (1) | KR830002757A (en) |
AR (1) | AR228256A1 (en) |
AU (1) | AU5848480A (en) |
DD (1) | DD150609A5 (en) |
DK (1) | DK214480A (en) |
ES (1) | ES491514A0 (en) |
FI (1) | FI801600A (en) |
GB (1) | GB2052487B (en) |
GR (1) | GR68453B (en) |
IE (1) | IE49803B1 (en) |
IL (1) | IL60086A (en) |
MA (1) | MA18829A1 (en) |
NO (1) | NO801469L (en) |
NZ (1) | NZ193730A (en) |
OA (1) | OA06533A (en) |
PL (1) | PL224313A1 (en) |
PT (1) | PT71251A (en) |
ZA (1) | ZA802909B (en) |
ZW (1) | ZW11880A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8372850B2 (en) | 2006-11-02 | 2013-02-12 | Vertex Pharmaceuticals Incorporated | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
US8383633B2 (en) | 2007-05-02 | 2013-02-26 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8410133B2 (en) | 2007-03-09 | 2013-04-02 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
US8426425B2 (en) | 2006-12-19 | 2013-04-23 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
US8455507B2 (en) | 2007-04-13 | 2013-06-04 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8518953B2 (en) | 2007-03-09 | 2013-08-27 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
US8524720B2 (en) | 2000-09-15 | 2013-09-03 | Vertex Pharmaceuticals Incorporated | Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
US8557833B2 (en) | 2005-11-03 | 2013-10-15 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8633210B2 (en) | 2000-09-15 | 2014-01-21 | Vertex Pharmaceuticals Incorporated | Triazole compounds useful as protein kinase inhibitors |
US8653088B2 (en) | 2003-02-06 | 2014-02-18 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
US8664219B2 (en) | 2007-03-09 | 2014-03-04 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
US8785444B2 (en) | 2007-05-02 | 2014-07-22 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507146A (en) * | 1982-12-28 | 1985-03-26 | Ciba-Geigy Corporation | 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity |
DE3829469A1 (en) * | 1988-08-31 | 1990-03-01 | Bayer Ag | METHOD FOR THE PRODUCTION OF SUBSTITUTED N-AZINYL-N'-SULFONYL-ISOTHIO-UREAS AND N-AZINYL-IMINODITHIOCARBONIC ACID-S, S-DIESTER AS INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION |
CA2269971A1 (en) * | 1997-09-03 | 1999-03-11 | Trent Lee Abraham | Pyrimidine derivatives |
US7473691B2 (en) | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
CN100436452C (en) | 2000-12-21 | 2008-11-26 | 沃泰克斯药物股份有限公司 | Pyrazole compounds useful as protein kinase inhibitors |
EP2140864A3 (en) * | 2001-01-31 | 2010-01-27 | H.Lundbeck A/S | Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods |
EP1483247B1 (en) | 2002-03-13 | 2009-06-24 | Euro-Celtique S.A. | Aryl substituted pyrimidines and the use thereof |
EP1485380B1 (en) | 2002-03-15 | 2010-05-19 | Vertex Pharmaceuticals Incorporated | Azolylaminoazines as inhibitors of protein kinases |
DE60314730T2 (en) * | 2002-03-15 | 2008-06-05 | Ciba Specialty Chemicals Holding Inc. | USE OF 4-AMINOPYRIMIDINES FOR ANTIMICROBIAL TREATMENT OF SURFACES |
MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
CN101037438A (en) | 2002-08-02 | 2007-09-19 | 沃泰克斯药物股份有限公司 | Compositions useful as inhibitors of GSK-3 |
CA2619517A1 (en) | 2005-08-18 | 2007-02-22 | Michael Mortimore | Pyrazine kinase inhibitors |
CA2694499A1 (en) | 2007-07-31 | 2009-02-05 | Vertex Pharmaceuticals Incorporated | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
WO2010027921A1 (en) | 2008-09-03 | 2010-03-11 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical formulations comprising the same |
TW201639852A (en) * | 2008-12-09 | 2016-11-16 | 吉李德科學股份有限公司 | Intermediate compounds for preparation of compounds useful as modulators of toll-like receptors |
KR102328682B1 (en) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | Novel heterocyclicamine derivatives and pharmaceutical composition comprising the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754832A (en) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | IMINAZOLINES |
-
1980
- 1980-05-05 MA MA19025A patent/MA18829A1/en unknown
- 1980-05-13 DD DD80221082A patent/DD150609A5/en unknown
- 1980-05-14 ES ES491514A patent/ES491514A0/en active Granted
- 1980-05-15 NZ NZ193730A patent/NZ193730A/en unknown
- 1980-05-15 IL IL60086A patent/IL60086A/en unknown
- 1980-05-16 NO NO801469A patent/NO801469L/en unknown
- 1980-05-16 IE IE1023/80A patent/IE49803B1/en unknown
- 1980-05-16 ZA ZA00802909A patent/ZA802909B/en unknown
- 1980-05-16 AU AU58484/80A patent/AU5848480A/en not_active Abandoned
- 1980-05-16 EP EP80102724A patent/EP0019811A1/en not_active Withdrawn
- 1980-05-16 GB GB8016309A patent/GB2052487B/en not_active Expired
- 1980-05-16 ZW ZW118/80A patent/ZW11880A1/en unknown
- 1980-05-16 GR GR61963A patent/GR68453B/el unknown
- 1980-05-16 DK DK214480A patent/DK214480A/en not_active Application Discontinuation
- 1980-05-16 FI FI801600A patent/FI801600A/en not_active Application Discontinuation
- 1980-05-16 PT PT71251A patent/PT71251A/en unknown
- 1980-05-17 JP JP6586380A patent/JPS55154971A/en active Pending
- 1980-05-17 PL PL22431380A patent/PL224313A1/xx unknown
- 1980-05-17 KR KR1019800001944A patent/KR830002757A/en unknown
- 1980-05-17 OA OA57113A patent/OA06533A/en unknown
- 1980-05-19 AR AR281109A patent/AR228256A1/en active
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8524720B2 (en) | 2000-09-15 | 2013-09-03 | Vertex Pharmaceuticals Incorporated | Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
US8633210B2 (en) | 2000-09-15 | 2014-01-21 | Vertex Pharmaceuticals Incorporated | Triazole compounds useful as protein kinase inhibitors |
US8653088B2 (en) | 2003-02-06 | 2014-02-18 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
US8637511B2 (en) | 2005-11-03 | 2014-01-28 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8557833B2 (en) | 2005-11-03 | 2013-10-15 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8372850B2 (en) | 2006-11-02 | 2013-02-12 | Vertex Pharmaceuticals Incorporated | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
US8426425B2 (en) | 2006-12-19 | 2013-04-23 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
US8518953B2 (en) | 2007-03-09 | 2013-08-27 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
US8410133B2 (en) | 2007-03-09 | 2013-04-02 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
US8664219B2 (en) | 2007-03-09 | 2014-03-04 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
US8735593B2 (en) | 2007-03-09 | 2014-05-27 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
US8455507B2 (en) | 2007-04-13 | 2013-06-04 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8383633B2 (en) | 2007-05-02 | 2013-02-26 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
US8785444B2 (en) | 2007-05-02 | 2014-07-22 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
MA18829A1 (en) | 1980-12-31 |
AU5848480A (en) | 1980-11-20 |
PT71251A (en) | 1980-06-01 |
PL224313A1 (en) | 1981-02-13 |
NO801469L (en) | 1980-11-19 |
GB2052487A (en) | 1981-01-28 |
ES8104279A1 (en) | 1981-04-16 |
GR68453B (en) | 1981-12-30 |
FI801600A (en) | 1980-11-19 |
KR830002757A (en) | 1983-05-30 |
IL60086A0 (en) | 1980-07-31 |
EP0019811A1 (en) | 1980-12-10 |
JPS55154971A (en) | 1980-12-02 |
AR228256A1 (en) | 1983-02-15 |
IE801023L (en) | 1980-11-18 |
OA06533A (en) | 1981-07-31 |
IE49803B1 (en) | 1985-12-25 |
IL60086A (en) | 1984-03-30 |
ZA802909B (en) | 1981-05-27 |
NZ193730A (en) | 1982-12-21 |
DD150609A5 (en) | 1981-09-09 |
ES491514A0 (en) | 1981-04-16 |
ZW11880A1 (en) | 1980-12-17 |
DK214480A (en) | 1980-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2052487B (en) | Pyrimidine compounds and pharmaceutical preprations containing them | |
PH23005A (en) | Heterocyclic compounds and pharmaceutical preparation containing the same | |
JPS5659706A (en) | Novel composition useful for cosmetic and drug | |
PH15980A (en) | 2-imidazoline derivatives and pharmaceutical composition | |
DE3168067D1 (en) | 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them | |
GB2125401B (en) | Desoxyuridine derivatives and their use as pharmaceuticals | |
JPS5618982A (en) | Pyrimidine derivatives and medicinal drug containing them | |
PH17759A (en) | Benzodiazepine compounds and their use as pharmaceuticals | |
IL64054A (en) | Imidazolylpyridines and pharmaceutical compositions containing them | |
DE3066406D1 (en) | Diaryl compounds and pharmaceutical formulations containing them | |
IL61117A0 (en) | Acetoxymethyl-penem compounds and pharmaceutical compositions containing them | |
IL60376A (en) | 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them | |
ZA817796B (en) | Use of anticholenergic drugs | |
GB2048671B (en) | Pharmaceutical composition containing dihydroegotoxine | |
EP0054416A3 (en) | Benzodiazepine compounds and their use as pharmaceuticals | |
PH16060A (en) | Pyrimidine derivatives and pharmaceutical preparation thereof | |
DE2966178D1 (en) | Compounds of the muramyl-peptide type and medicines containing them | |
IL59177A0 (en) | Spiro-quinolylhydantoins and pharmaceutical compositions containing them | |
GB2048250B (en) | 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses | |
GB2080809B (en) | Phenoxyisobutyrates of moroxydin and drugs containing them | |
IL60695A (en) | Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them | |
IL61038A0 (en) | 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them | |
IL60332A0 (en) | Pyridylaminotriazole derivatives and pharmaceutical compositions containing them | |
IL62146A (en) | Guanylamidines and pharmaceutical compositions containing them | |
PH17683A (en) | Benzocycloheptenes and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |